ARCHIVES

FDA Approves Herceptin For HER2+ Metastatic Stomach Cancers

This article is from The Cancer Letter archive.

Vol. 36 No. 38 | October 22, 2010

Download PDF Visit The Full Archive

Related Articles

Formal Guidelines For Training Grants Developed By NCI

December 7, 1979

In Brief: ASCO Selects Four New Board Members; Mount Sinai’s Shank To Move To California

March 27, 1998

In Brief: New Spending Plan Funds NIH At FY95 Level; Continuing Resolution Expires Dec. 15

November 24, 1995

NCAB Working Group Appointed To Review NCI Progress

April 30, 2010

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994

President’s Cancer Panel Special Commission On Breast Cancer Named

April 25, 1992